Attached files
file | filename |
---|---|
10-K - MEDLINK INTERNATIONAL, INC FORM 10-K - MEDLINK INTERNATIONAL, INC. | form10-k.htm |
EX-31.1 - EXHIBIT 31.1 - MEDLINK INTERNATIONAL, INC. | ex-31_1.htm |
EX-32.1 - EXHIBIT 32.1 - MEDLINK INTERNATIONAL, INC. | ex-32_1.htm |
EX-32.2 - EXHIBIT 32.2 - MEDLINK INTERNATIONAL, INC. | ex-32_2.htm |
Exhibit
31.2
CERTIFICATION
I, James
Rose, certify that:
1.
I have reviewed this annual report on Form 10-K of MedLink International,
Inc.;
2.
Based on my knowledge, this annual report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this annual
report;
3.
Based on my knowledge, the financial statements, and other financial information
included in this annual report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this annual report;
4.
The registrant’s other certifying officer and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal controls over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:
|
a)
designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;
|
|
b)
designed such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting
principles;
|
|
c)
evaluated the effectiveness of the registrant’s disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such
evaluation;
|
|
d)
disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial
reporting;
|
5.
The registrant’s other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant’s auditors and the audit committee of
the registrant’s board of directors (or persons performing the equivalent
function):
a) all
significant deficiencies in the design or operation of internal controls which
could adversely affect the registrant’s ability to record, process, summarize
and report financial data and have identified for the registrant’s auditors any
material weaknesses in internal controls; and
b) any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant’s internal controls over financial
reporting.
Dated: April
15, 2010
|
By:
|
/s/
James Rose
|
James
Rose
|
||
Chief
Financial Officer
|